Print Friendly, PDF & Email

CLIENT FOCUS: Cosmos Health Gets 32.5M In Public Offering

DHC Client Cosmos Health Gets 32.5M In Public Offering

December 30, 2022 – Elliot Lutzker, Partner and Chair of the Corporate & Securities law practice along with Partner, Charles Capetanakis, Corporate Counsel announced that client, Cosmos Health Inc. (Nasdaq: COSM), a global healthcare group completed a public offering for the sale of $32.5 Million of the Company’s common stock and warrants at $11.50 per unit.

Cosmos Health Inc., a pharmaceutical holding company headquartered in Chicago, Illinois with facilities in Greece and the U.K., provides proprietary lines of nutraceuticals and distributes pharmaceuticals, branded generics, OTC medications and medical devices.

The offering included participation from Grigorios Siokas, CEO of Cosmos Health Inc., as well as existing shareholders of the Company.

Cosmos will use the net proceeds from the offering for working capital and general corporate purposes, A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.

For further information, please contact Charles Capetanakis ( or Elliot H. Lutzker (

Stay up to date

Subscribe to receive the latest insights and news from DHC.